Okay, @gdombal I will concede that Boston is the center of the universe for biopharma/biotech (for now), though I maintain Minnesota still retains its dominance in all… Read more
Nsight Barbara Nelsen on the business of science.
Just over 10 years ago, Shinya Yamanaka, a stem-cell scientist at Japan’s Kyoto University, discovered that mature adult cells could be reprogrammed back into an… Read more
With the start of the new year and JP Morgan next week, it’s time to start planning your 2017 life science capital investment campaign. Here are… Read more
In Part 1 of this series, we highlight what investors want to see in a company’s business plan and hear in the pitch in order… Read more
From seed stage through exit, convertible debt to reverse merger, funding strategies are critical for companies to secure the capital necessary for success. To help… Read more